Increased recurrences using intensity-modulated radiation therapy in the postoperative setting

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 33, Issue 6, 2010, Pages 599-603

  Turaka, Aruna ^a   Li, Tianyu ^a   Sharma, Navesh K ^a   Li, Linna ^a   Nicolaou, Nicos ^a   Mehra, Ranee ^b   Burtness, Barbara ^b   Cohen, Roger B ^b   Lango, Miriam N ^c   Horwitz, Eric M ^a   Ridge, John A ^c   Feigenberg, Steven J ^a  

^a Departments of Radiation Oncology   (United States)

^b Fox Chase Cancer Center   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Head and neck cancers; IMRT; Patterns of failure.; PORT

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL; HYDROXYUREA; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; RADIATION DOSE; SMOKING HABIT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT DURATION; TREATMENT FAILURE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 78649986378     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181c4c3cc     Document Type: Article

References (10)

1. Cannon DM, Lee NY. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;70:660-665.
2. Harari PM. Beware the swing and a miss: baseball precautions for conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:657-659.
3. Schoenfeld GO, Amdur RJ, Morris CG, et al. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;71:377-385.
4. Lee N, Xia P, Fischbein NJ, et al. Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49-60.
5. Yao M, Dornfeld KJ, Buatti JM, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys. 2005;63:410-421.
6. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
7. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28-42.
8. Gregoire V, Eisbruch A, Hamoir M, et al. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol. 2006;79:15-20.
9. Khuntia D, Harris J, Bentzen S. Increased oral mucositis after IMRT versus Non-IMRT when combined with cetuximab and cisplatin or docetaxel for head and neck cancer: preliminary results of RTOG 0234. Int J Radiat Oncol Biol Phys. 2008;72:S33.
10. Rosenthal DI, Chambers MS, Fuller CD, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72:747-755.